Related Experiment Video
Updated: Apr 18, 2026
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
Nanoparticle-based mechanistic and multifunctional strategies for targeted osteosarcoma therapy
Jie Cai1, Hulin Yang1, Zongxian He1
1Department of Orthopedics, The First People's Hospital of Xiaoshan District, Xiaoshan Affiliated Hospital of Wenzhou Medical University, Hangzhou, 311200, China.
Abstract:
Osteosarcoma is the most common malignant bone tumor in children and adolescents, usually affecting the long bones of the limbs. Despite progress in surgery, chemotherapy, and radiotherapy, patient outcomes remain poor, highlighting the need for better treatments. Nanoparticles have emerged as promising platforms for targeted osteosarcoma therapy, offering selective drug delivery, controlled release, and multifunctional treatment options that improve efficacy and reduce toxicity. Stimulus-responsive nanoparticles further enhance precision by reacting to specific cues in the tumor microenvironment. However, challenges such as biological toxicity, bioaccumulation, stability, and clearance must be addressed. This review summarizes nanoparticle classifications and stimulus-responsive mechanisms in osteosarcoma therapy, discusses current limitations, and highlights future directions, including the development of biodegradable, personalized, and multifunctional nanoparticles and the integration of artificial intelligence to optimize design and accelerate clinical translation.
Insights
Nanoparticles offer targeted delivery for osteosarcoma treatment, improving efficacy and reducing toxicity. Future research focuses on biodegradable, personalized nanoparticles and AI integration for better outcomes in pediatric bone cancer.
Area of Science:
- Biomedical Engineering
- Oncology
- Nanotechnology
Background:
- Osteosarcoma is a prevalent pediatric bone cancer with poor outcomes despite current treatments.
- Nanoparticles show promise for targeted drug delivery in osteosarcoma therapy.
- Stimulus-responsive nanoparticles offer enhanced precision by targeting tumor microenvironment cues.
Purpose of the Study:
- To review nanoparticle classifications and stimulus-responsive mechanisms for osteosarcoma therapy.
- To discuss current limitations and challenges in nanoparticle-based osteosarcoma treatment.
- To highlight future directions for optimizing nanoparticle design and clinical translation.
Main Methods:
- Literature review of nanoparticle classifications.
- Analysis of stimulus-responsive mechanisms in osteosarcoma.
- Discussion of challenges and future research directions.
Main Results:
- Nanoparticles provide selective drug delivery, controlled release, and multifunctional treatment options.
- Stimulus-responsive nanoparticles enhance therapeutic precision.
- Key challenges include biological toxicity, bioaccumulation, stability, and clearance.
Conclusions:
- Nanoparticles are a promising platform for advanced osteosarcoma therapy.
- Addressing challenges and developing biodegradable, personalized, and multifunctional nanoparticles is crucial.
- Integrating artificial intelligence can accelerate the clinical translation of these therapies.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
01:24Modified-Release Drug Delivery Systems: Site-Targeted
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...